Phase 3 Clinical Study of AK112 for NSCLC Patients

计划入组 322 人 · 首次发布于 2022 年 1 月 11 日

ClarVista HARMONI Toric Trial With Intraoperative Exchange

计划入组 44 人 · 首次发布于 2017 年 2 月 15 日

Yoga Asana Chandra Harmoni on Psychological Well-being and Learning Readiness Among Medical Students

计划入组 80 人 · 首次发布于 2025 年 9 月 12 日

Coenzyme A

C₂₁H₃₆N₇O₁₆P₃S · Rx

Acitretin(Soriatane)

C₂₁H₂₆O₃ · Rx

Tretinoin(Altreno, Atralin, Biacna, Refissa, Renova, Retin-A, Stieva-A, Tri-luma, Twyneo, Veltin, Vesanoid, Ziana)

C₂₀H₂₈O₂

A&A SMALL CHANGES HANDYPEOPLE

United States

Novozymes A/S

Denmark

Ambu A/S

Denmark

Ivonescimab Demonstrates Superior PFS Over Pembrolizumab in PD-L1 Positive NSCLC

Benmelstobart Plus Anlotinib Shows Promise in EGFR-Mutated NSCLC After TKI Failure

Akeso Reports Record Sales Growth as Ivonescimab Meets Overall Survival Endpoint in Phase III Trial